title: Results of chemotherapy in advanced carcinoma of the fallopian tube.
abstract: Forty-six patients with measurable disease received chemotherapy for advanced primary or recurrent carcinoma of the fallopian tube. The response rate was 9% with single-agent therapy, 29% with multiagent therapy without cisplatin, and 81% with cisplatin-containing combination therapy. Survival was significantly improved in Stage III/IV with the addition of cisplatin-based combination therapy.
authors.affiliation: Puget Sound Oncology Consortium, Seattle, WA.
authors.forename: W A
authors.initials: WA
authors.lastname: Peters
authors.forename: W A
authors.initials: WA
authors.lastname: Andersen
authors.forename: M P
authors.initials: MP
authors.lastname: Hopkins
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002699:Chlorambucil / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005185:Fallopian Tube Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging
chemical_list: D000970:Antineoplastic Agents; D002699:Chlorambucil; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin